- Barclays upgraded Humana to Overweight from Neutral
Barclays raised Humana to Overweight from Neutral, lifting the price target to $515 from $407. The firm estimates a 75% probability that Humana's key contract H5216 will regain bonus eligibility in the upcoming Medicare star ratings, expected around Oct. 8. Humana stock rose more than 8% to $411.93.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.